To the annoyance of some shareholders, Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) shares are down a considerable 27% in the last month, which continues a horrid run for the company. For any long-term ...
Source LinkTo the annoyance of some shareholders, Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) shares are down a considerable 27% in the last month, which continues a horrid run for the company. For any long-term ...
Source Link
Comments